A-Ret Gel 0.05% Menarini — Research Summary
A-Ret Gel 0.05% Menarini is a pharmaceutical tretinoin formulation extensively researched for keratinocyte differentiation and cellular proliferation studies. Tretinoin, the active compound, is a first-generation retinoid derived from vitamin A that modulates gene expression through retinoic acid receptor activation. This Menarini-manufactured gel formulation provides standardised 0.05% concentration for consistent laboratory research protocols. Researchers investigating Stroid UK Shop frequently examine tretinoin’s effects on cellular turnover, collagen synthesis modulation, and transcriptional regulation pathways in controlled laboratory environments.
Laboratory Research Applications
Tretinoin demonstrates significant utility in cellular biology research, particularly studies examining epidermal differentiation and photoaging mechanisms. Laboratory investigations focus on its interaction with retinoic acid receptors (RAR) and retinoid X receptors (RXR), which regulate gene transcription involved in cellular proliferation and differentiation. Research teams studying tretinoin compounds analyse its effects on extracellular matrix remodeling, inflammatory mediator expression, and comedogenesis prevention in keratinocyte cell cultures. Advanced research protocols examine concentration-dependent responses and time-course studies to evaluate optimal experimental parameters.
Product Specifications
| Parameter | Value |
|---|---|
| Active Compound | Tretinoin |
| Concentration | 0.05% |
| Formulation | Topical Gel |
| Manufacturer | Menarini |
| CAS Number | 302-79-4 |
| Storage Temperature | 15-25°C |
This pharmaceutical-grade formulation ensures consistent potency for reproducible research outcomes. Researchers utilising tretinoin in comparative studies with other bioactive compounds appreciate the standardised manufacturing specifications. Storage protocols require protection from light and temperature-controlled environments to maintain chemical stability. Quality assurance documentation supports research-grade applications requiring pharmaceutical-standard materials.
Research Compliance
A-Ret Gel 0.05% Menarini is supplied exclusively for in-vitro laboratory research purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must ensure appropriate institutional oversight and safety protocols when handling this pharmaceutical-grade tretinoin formulation.
